A complementary component to atypical haemolytic uraemic syndrome
Related Experiment Video
Updated: May 10, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Vanita Gandhi1, Aine Burns, Timothy Goodship
1Department of Nephrology, Royal Free Hospital NHS Trust, London, UK. vanita.gandhi@doctors.org.uk
We describe a case of a 22-year-old man who presented with clinical features of atypical haemolytic uraemic syndrome and in whom genetic analysis of complement regulatory proteins demonstrated a CD46 mutation. He was treated with plasma exchange, intermittent haemodialysis and blood transfusions. At 6-month follow-up his haematological parameters and renal function showed complete resolution, and he experienced no further disease recurrence in the subsequent year.
We describe a case of a 22-year-old man who presented with clinical features of atypical haemolytic uraemic syndrome and in whom genetic analysis of complement regulatory proteins demonstrated a CD46 mutation. He was treated with plasma exchange, intermittent haemodialysis and blood transfusions. At 6-month follow-up his haematological parameters and renal function showed complete resolution, and he experienced no further disease recurrence in the subsequent year.
Related Concept Videos
Complement System
Hypersensitivity Reactions: Cytolytic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
Urinary Tract Infection II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction